Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 173.57%14.87B | -36.54%5.44B | 98.50%8.57B | 18.57%4.32B | 31.57%3.64B | -29.35%2.77B | -9.99%3.92B | 2.33%4.35B | 113.40%4.25B | -3.52%1.99B |
Net profit before non-cash adjustment | 23.12%12.71B | 31.99%10.32B | 270.93%7.82B | -14.11%2.11B | -4.57%2.45B | -10.04%2.57B | -30.41%2.86B | 37.15%4.11B | 87.13%3B | -18.07%1.6B |
Total adjustment of non-cash items | 12.74%1.44B | 113.52%1.28B | -3.84%599M | -61.99%622.89M | 18.25%1.64B | 4.06%1.39B | -6.62%1.33B | 3.03%1.43B | -14.04%1.38B | 64.15%1.61B |
-Depreciation and amortization | 33.73%2.72B | 22.46%2.03B | 4.10%1.66B | -3.29%1.6B | 19.16%1.65B | 3.68%1.38B | -1.29%1.34B | 14.53%1.35B | 12.71%1.18B | 5.19%1.05B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --3.02M | ---- | --144.55M | ---- | ---- | ---- | --799.78M |
-Disposal profit | -300.00%-26M | 533.33%13M | -149.58%-3M | 91.72%-1.2M | 92.51%-14.52M | -473.47%-193.83M | -79.32%-33.8M | -309.29%-18.85M | -123.96%-4.61M | 7.77%19.22M |
-Net exchange gains and losses | -125.89%-698M | 23.13%-309M | -731.23%-402M | -144.42%-48.36M | 63.53%108.88M | 2,763.12%66.58M | -100.81%-2.5M | 55.90%308.4M | 158.11%197.81M | -21.89%-340.41M |
-Other non-cash items | -20.70%-554M | 30.14%-459M | 29.06%-657M | -778.03%-926.09M | -558.14%-105.47M | -149.08%-16.03M | 115.10%32.66M | -2,334.27%-216.3M | -88.42%9.68M | -66.03%83.59M |
Changes in working capital | 111.70%721M | -4,236.24%-6.16B | -90.60%149M | 449.31%1.58B | 61.93%-453.6M | -333.33%-1.19B | 76.78%-274.96M | -823.86%-1.18B | 89.48%-128.17M | -40.11%-1.22B |
-Change in receivables | 13.62%-1.86B | -179.12%-2.15B | -732.66%-771M | -92.74%121.87M | 382.96%1.68B | -9.00%-593.59M | -9,107.98%-544.56M | -102.19%-5.91M | 118.34%269.43M | -225.58%-1.47B |
-Change in inventory | 143.20%2.87B | -302.18%-6.64B | -648.29%-1.65B | 132.32%301.3M | -24.12%-932.31M | -5,047.43%-751.17M | 98.60%-14.59M | 33.06%-1.05B | -144.29%-1.56B | -177.62%-639.63M |
-Change in payables | -123.50%-490M | 49.78%2.09B | 268.24%1.39B | 136.05%378.01M | -1,073.41%-1.05B | 79.44%107.72M | 139.21%60.03M | -114.85%-153.11M | 528.33%1.03B | -299.56%-240.78M |
-Provision for loans, leases and other losses | -182.76%-72M | 166.92%87M | -142.97%-130M | 16,894.49%302.5M | -98.20%1.78M | 105.86%98.81M | -74.51%48M | -21.56%188.3M | 98.81%240.04M | 16.59%120.74M |
-Changes in other current assets | -90.09%-211M | 62.75%-111M | -395.33%-298M | -166.43%-60.16M | 123.75%90.56M | -1,817.14%-381.3M | 93.72%-19.89M | -211.31%-316.84M | -112.73%-101.78M | 948.15%799.78M |
-Changes in other current liabilities | -15.56%483M | -64.43%572M | 197.24%1.61B | 321.04%540.98M | -174.61%-244.75M | 67.33%328.05M | 31.19%196.06M | 3,314.52%149.44M | -102.21%-4.65M | 166.14%210.38M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -39.29%-78M | -107.41%-56M | 25.83%-27M | 26.41%-36.4M | -259.24%-49.47M | -9.05%-13.77M | 3.49%-12.63M | 34.61%-13.08M | -9.12%-20.01M | 22.21%-18.34M |
Interest received (cash flow from operating activities) | -8.49%97M | 130.43%106M | 47.09%46M | -26.85%31.27M | 12.56%42.75M | 11.70%37.98M | 56.57%34M | 31.45%21.72M | 44.40%16.52M | -5.84%11.44M |
Tax refund paid | 0.33%-3.01B | -109.29%-3.02B | -83.64%-1.44B | 6.40%-785.23M | -50.96%-838.9M | 53.25%-555.71M | -4.67%-1.19B | -77.90%-1.14B | 28.52%-638.34M | -44.48%-893.08M |
Other operating cash inflow (outflow) | 16.15%604M | 81.82%520M | -71.74%286M | 483.20%1.01B | 262.40%173.55M | 36.22%47.89M | 102.66%35.16M | -38.77%17.35M | 141.06%28.33M | -103.38%-69M |
Operating cash flow | 317.83%12.49B | -59.77%2.99B | 63.74%7.43B | 52.89%4.54B | 30.00%2.97B | -17.99%2.28B | -14.11%2.78B | -10.91%3.24B | 255.51%3.64B | -26.98%1.02B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -90.52%-6.53B | -292.22%-3.43B | -25.40%-874M | 51.60%-697M | -0.19%-1.44B | -54.21%-1.44B | 64.06%-932.02M | 25.97%-2.59B | -90.49%-3.5B | -156.58%-1.84B |
Net intangibles purchase and sale | -5.13%-901M | -5.15%-857M | -141.97%-815M | -524.24%-336.81M | -3.14%-53.96M | 62.34%-52.32M | 17.66%-138.9M | -43.27%-168.69M | -48.99%-117.74M | 56.36%-79.03M |
Net business purchase and sale | ---- | ---- | ---250M | --0 | -36.07%-176.4M | ---129.64M | ---- | ---- | ---- | ---- |
Net investment product transactions | 390.91%128M | 87.43%-44M | -496.02%-350M | -132.53%-58.72M | 418.64%180.54M | ---56.66M | --0 | ---12.49M | --0 | -103.70%-50M |
Advance cash and loans provided to other parties | -20.00%-12M | -400.00%-10M | 79.31%-2M | 23.87%-9.67M | -176.09%-12.7M | 69.57%-4.6M | -67.85%-15.12M | 7.64%-9.01M | 49.71%-9.75M | -86.40%-19.39M |
Repayment of advance payments to other parties and cash income from loans | 30.77%17M | 62.50%13M | -29.67%8M | -12.59%11.38M | -20.89%13.01M | -1.95%16.45M | -38.64%16.78M | -13.82%27.34M | -24.26%31.73M | -9.94%41.89M |
Net changes in other investments | 43.94%-74M | -4,300.00%-132M | -112.62%-3M | 645.15%23.77M | -115.33%-4.36M | 128.04%28.45M | -225.10%-101.48M | 319.62%81.11M | 72.84%-36.93M | -202.32%-135.99M |
Investing cash flow | -65.39%-7.37B | -95.01%-4.46B | -114.24%-2.29B | 28.57%-1.07B | 8.67%-1.49B | -39.71%-1.64B | 56.23%-1.17B | 26.42%-2.67B | -74.67%-3.64B | -567.15%-2.08B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 231.19%3.72B | 278.38%1.12B | -10.46%-629M | 2.67%-569.44M | 10.54%-585.08M | -36.58%-654.04M | -119.45%-478.86M | 144.69%2.46B | -20.72%1.01B | 256.32%1.27B |
Net common stock issuance | -297.38%-1.06B | 16.04%-267M | -836,742.11%-318M | -442.86%-38K | 81.58%-7K | ---38K | ---- | 53.95%-175K | ---380K | ---- |
Increase or decrease of lease financing | -72.19%-613M | -3.49%-356M | -16.04%-344M | -9.53%-296.46M | ---270.67M | ---- | ---- | ---- | ---- | ---- |
Cash dividends paid | -27.92%-1.23B | -46.34%-960M | -66.13%-656M | 10.71%-394.87M | 0.12%-442.23M | -2.90%-442.76M | 3.58%-430.28M | -36.90%-446.27M | 13.89%-325.97M | -16.53%-378.57M |
Cash dividends for minorities | ---20M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net other fund-raising expenses | -57.89%-30M | -11.76%-19M | 17.04%-17M | -5.08%-20.49M | -544.34%-19.5M | 145.02%4.39M | -237.16%-9.75M | -82.88%7.11M | 197.72%41.53M | -306.59%-42.49M |
Financing cash flow | 259.17%764M | 75.56%-480M | -53.28%-1.96B | 2.75%-1.28B | -20.60%-1.32B | -18.89%-1.09B | -145.43%-918.89M | 180.40%2.02B | -14.94%721.33M | 173.92%848M |
Net cash flow | ||||||||||
Beginning cash position | -6.39%16.42B | 33.23%17.54B | 20.47%13.16B | 0.24%10.93B | -5.94%10.9B | 7.17%11.59B | 28.07%10.82B | 6.06%8.45B | 1.66%7.96B | 14.27%7.83B |
Current changes in cash | 401.69%5.88B | -161.29%-1.95B | 45.25%3.18B | 1,298.07%2.19B | 135.19%156.6M | -164.08%-444.97M | -73.18%694.36M | 257.42%2.59B | 445.18%724.36M | -129.98%-209.85M |
Effect of exchange rate changes | 6.41%880M | -30.74%827M | 2,416.86%1.19B | 136.23%47.44M | 46.35%-130.96M | -400.81%-244.11M | 137.11%81.15M | 9.59%-218.68M | -171.11%-241.87M | 22.28%340.14M |
Cash adjustments other than cash changes | 0.00%2M | --2M | ---- | ---- | 0.00%-1K | ---1K | ---- | ---1K | ---- | 0.00%1K |
End cash Position | 41.19%23.18B | -6.39%16.42B | 33.22%17.54B | 20.47%13.16B | 0.24%10.93B | -5.94%10.9B | 7.17%11.59B | 28.07%10.82B | 6.06%8.45B | 1.66%7.96B |
Free cash flow | 474.18%5.01B | -123.37%-1.34B | 63.79%5.73B | 138.01%3.5B | 149.75%1.47B | -65.25%588.83M | 253.76%1.69B | 3,022.05%479.02M | 101.71%15.34M | -278.95%-899.23M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |